Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 185 (RN7SKP185) is a genomic sequence classified as a pseudogene, meaning it is a non-functional copy of the RNA, 7SK small nuclear gene. Pseudogenes typically arise from duplication or retrotransposition events and do not produce functional RNA or protein. Unlike the functional RN7SK gene, which encodes a small nuclear RNA involved in regulation of transcription elongation and cellular differentiation, RN7SKP185 lacks demonstrated biological activity, disease association, or relevance as a therapeutic target[3]. The parent gene RN7SK (not the pseudogene) is a well-described long non-coding RNA that regulates transcription elongation by binding P-TEFb, influences immune cell polarization, differentiation, and cell proliferation[1][2][3]. Note: If you are interested in the biologically relevant molecule, refer instead to "RNA, 7SK small nuclear RNA (RN7SK)" and not the pseudogene RN7SKP185.
None applicable; RN7SKP185 does not produce a protein or functional RNA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 185 (RN7SKP185).